The Role of SMEs in New Biobased Value Chains Roger A. Sheldon CEO - - PowerPoint PPT Presentation

the role of smes in new biobased value chains
SMART_READER_LITE
LIVE PREVIEW

The Role of SMEs in New Biobased Value Chains Roger A. Sheldon CEO - - PowerPoint PPT Presentation

The Role of SMEs in New Biobased Value Chains Roger A. Sheldon CEO CLEA Technologies Stakeholder Event Biobased Public Private Partnership BRIDGE Beatrix Gebouw, Jaarbeurs, Utrecht 21 May, 2013 The Value Chain Integrated biobased


slide-1
SLIDE 1

The Role of SMEs in New Biobased Value Chains

Beatrix Gebouw, Jaarbeurs, Utrecht 21 May, 2013 Stakeholder Event Biobased Public Private Partnership ‘BRIDGE’

Roger A. Sheldon CEO CLEA Technologies

slide-2
SLIDE 2

The Value Chain

Integrated biobased value chains

slide-3
SLIDE 3

Bridging the pillars – towards the Biobased Economy

slide-4
SLIDE 4

BRIDGE: the focus

  • Build new interconnections between different sectors
  • Build new biobased value chains (from feedstock to products)
  • Establish new co-operations throughout industry clusters
  • Develop innovative and sustainable biobased chemicals and

materials with locally sourced biomass and validated at demonstration scale

  • At least 5 flagships resulting from the PPP producing new

biobased materials, chemicals and fuels proven to be cost- competitive to the alternatives based on fossil resources

slide-5
SLIDE 5

SMEs in the innovation chain

slide-6
SLIDE 6

BRIDGE: the role of SMEs

  • Substantial role innovative SMEs in transition to a biobased

economy.

  • Specific technologies, services and equipment, enhancing

developments at large enterprises and in stand alone projects.

  • Capturing the potential of new technologies extremely fast,

thus driving the biobased economy as a whole.

  • Supportive measures for SMEs regarding financing, market

info, legal obstacles and international partnering.

  • Representation via SME clusters or individual membership.
slide-7
SLIDE 7
slide-8
SLIDE 8
slide-9
SLIDE 9
slide-10
SLIDE 10

Current individual SME members

  • Inkemia IUCT group ( www.inkemia.com) - high-tech company for industrial

technological innovation , developing and implementing new technologies in the chemical, pharmaceutical, and environmental fields.

  • CLEA Technologies ( www.cleatechnologies.com ) - develops green,

biocatalytic processes and has proprietary technology for enzyme immobilization as Cross-Linked Enzyme Aggregates (CLEAs).

  • Direvo (www.direvo.com) - develops and implements biology-based solutions

for partners and customers in the fast growing biomass conversion market.

  • Biobase Europe Pilot Plant (www.bbeu.org) - open innovation pilot and demo

facilities for the biobased economy.

  • Bioprocess Pilot Facility (www.tudelft.nl) – cooperation South-Holland, City
  • f Delft, TU Delft, CSM/Purac, DSM, other BE-Basic partners.
  • BioNET Ingenieria (www.bionet.com ) - provides equipment and engineering

for biotech, chemical, food and pharma industries

slide-11
SLIDE 11

CLEA Technologies: Overview

  • CLEA Technologies B.V. since 2002
  • Currently 15 employees
  • Contract research in biocatalytic process development
  • Enzyme screening and immobilization
  • Proprietary patented technology
  • Cross Linked Enzyme Aggregates (CLEAs)
slide-12
SLIDE 12

Contract research: development of green biocatalytic processes Custom immobilization of enzymes on exclusive basis Off the shelf products

  • Immobilized Enzymes (CLEAs and other preparations)
  • Free Enzymes (consistent activity and technical service)
  • Discovery Platforms (selection of free or immobilized

biocatalysts all available on industrial scale)

Products and Services

slide-13
SLIDE 13

Enzyme Producers Enzyme Customers Novozymes Dupont DSM Evonik BASF Lonza Pfizer

  • Adding value to the biocatalyst / biocatalytic process
  • Working proactively with the customer to find optimum

solutions

The Enzyme Value Chain

CLEA Technologies

slide-14
SLIDE 14

Precipitation Precipitation X-linking X-linking X-linking + Co- polymerization X-linking + Co- polymerization X-linking + magnetic particles X-linking + magnetic particles

  • “Simple” & Broadly Applicable
  • Cost-effective (no need for pure enzyme)
  • Short Time-to-Market (low development costs)
  • Scalable Protocols

Our Technology

slide-15
SLIDE 15

What do we expect to achieve?

  • Establish new strategic technological

cooperations

  • Develop new markets for CLEAs
  • New contract research projects
  • New consortia for subsidy proposals
  • Support w.r.t. market data, financing,legal
  • bstacles, international partnering, etc.
slide-16
SLIDE 16

Bridging the innovation / implementation gap

Biobased research Biobased products

SMEs as Technology Providers

Thank you Any questions?

www.bridge2020.eu